APA (7th ed.) Citation

Mytilekas, V., Papaefstathiou, E., Koukourikis, P., Ouzounidis, X., Kazantzidis, S., & Hatzimouratidis, K. (2023). Testosterone castration levels in patients with prostate cancer: Is there a difference between GnRH agonist and GnRH antagonist? Primary results of an open-label randomized control study. Korean Urological Association.

Chicago Style (17th ed.) Citation

Mytilekas, Vaios-Konstantinos, Efstathios Papaefstathiou, Periklis Koukourikis, Xenofon Ouzounidis, Stavros Kazantzidis, and Konstantinos Hatzimouratidis. Testosterone Castration Levels in Patients with Prostate Cancer: Is There a Difference Between GnRH Agonist and GnRH Antagonist? Primary Results of an Open-label Randomized Control Study. Korean Urological Association, 2023.

MLA (9th ed.) Citation

Mytilekas, Vaios-Konstantinos, et al. Testosterone Castration Levels in Patients with Prostate Cancer: Is There a Difference Between GnRH Agonist and GnRH Antagonist? Primary Results of an Open-label Randomized Control Study. Korean Urological Association, 2023.